Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Krystexxa

PharmaCompass

01

Brand Name : Krystexxa

Pegloticase

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Krystexxa

arrow
Fi Europe 2024
Not Confirmed

Pegloticase

Main Therapeutic Indication : Rheumatology

Currency : USD

2023 Revenue in Millions : 272

2022 Revenue in Millions : 0

Growth (%) : Acquired from Horizon

blank